I am not sure Panasonic was that specific about its intentions with M43, as per my response to you in another thread. However, I don't really know so you may be right.OMDS is not limited by corporate priorities of a conglomerate with many layers like Panasonic. It does not appear that Panasonic will allow low end M43 to be developed. It is GH only which means a new body every 4 years with maybe some variants along the way (GH5s).
To be fair, the OM-1 was developed under Olympus and released after they divested the company to JIP. The OM-5 released by JIP is a warm make-over and re-badging of the EM5-Mk3."Little" OMDS launched two cameras last year. Panasonic launched one across both mounts.
It remains to be seen whether OMDS has the resources to continue with the type of major developments that the old Olympus was able to achieve by using the resources of its profitable medical instrument business. They may drift away to being more like another JIP brand, Sony Vaio - low investment in R&D, me-too products that are not leading edge. Time will tell.
It definitely was a quiet year for Panasonic in 2022 - they released the GH6 and two lenses. It will be interesting to see what 2023 looks like for them. At least they are starting early.
But I would say that it was a necessary first step.Sigma bodies are rather niche. Leica bodies are beyond the realm of Lumix shoppers. There is tremendous middle ground for Panasonic to occupy but L-mount is a distant 4th among FF market share. They need something to attract from Canon, Sony, Nikon user base but playing catch up with technology like PDAF is not the way.
--
Pete
Last edited: